Glyphic Biotechnologies

📍 New York City, United States🗓 Founded 2021👥 28 employees💰 Last funded Apr 2024
Biotechnology Research🌐 glyphic.bio
Website LinkedIn
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
7
Total investors
3
Early stage
4
Mid stage
0
Late stage
2021
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
7
Investor activity2021–2024 · investors recorded per year
202122022120244
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Glyphic Biotechnologies?
Glyphic Biotechnologies has 7 investors on record on gritt.io, including 3 early-stage backers, 4 mid-stage.
When did Glyphic Biotechnologies last raise funding?
The most recent investment in Glyphic Biotechnologies recorded on gritt.io was in April 2024.
When was Glyphic Biotechnologies founded?
Glyphic Biotechnologies was founded in 2021.
What industry is Glyphic Biotechnologies in?
Glyphic Biotechnologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Glyphic Biotechnologies based?
Glyphic Biotechnologies is headquartered in New York City, United States.